Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


05.08.2019

1 Am J Clin Oncol
1 Anticancer Res
4 Arch Ital Urol Androl
1 Asian J Transfus Sci
1 Biosci Biotechnol Biochem
1 BMJ Open Gastroenterol
1 Cancer
1 Cancer Med
1 Cancer Sci
1 Cell Prolif
1 Cell Signal
1 Clin Sci (Lond)
1 Dis Markers
2 Eur Urol
1 FASEB J
2 Front Oncol
1 Indian J Pathol Microbiol
1 Int Braz J Urol
2 Int J Biol Sci
4 Int J Urol
1 Intern Med
1 J Am Osteopath Assoc
1 J Cancer Res Clin Oncol
1 J Carcinog
1 J Clin Pathol
1 J Minim Invasive Gynecol
4 J Urol
1 Medicine (Baltimore)
1 Mol Cancer
1 Nat Cell Biol
2 Oncol Rep
2 PLoS One
1 Prog Urol
1 Urol Oncol
1 Urologe A
2 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. D'RUMMO KA, TenNapel MJ, Shen X
    The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy.
    Am J Clin Oncol. 2019 Jul 25. doi: 10.1097/COC.0000000000000582.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. AKITAKE M, Yamaguchi A, Shiota M, Imada K, et al
    Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer.
    Anticancer Res. 2019;39:4325-4328.
    PubMed     Text format     Abstract available


    Arch Ital Urol Androl

  3. ROMAGNOLI D, Mineo Bianchi F, Sadini P, Angiolini A, et al
    Pubis bone osteomyelitys after robotic radical cystectomy with continent intracorporeal urinary diversion: Multidisciplinary approach to a complex situation.
    Arch Ital Urol Androl. 2019;91:63-67.
    PubMed     Text format     Abstract available

  4. MINEO BIANCHI F, Romagnoli D, D'Agostino D, Salvaggio A, et al
    Posterior muscle-fascial reconstruction and knotless urethro-neo bladder anastomosis during robot-assisted radical cystectomy: Description of the technique and its impact on urinary continence.
    Arch Ital Urol Androl. 2019;91:5-10.
    PubMed     Text format     Abstract available

  5. DE ROSE AF, Balzarini F, Mantica G, Toncini C, et al
    Late urinary bladder metastasis from breast cancer.
    Arch Ital Urol Androl. 2019;91:60-62.
    PubMed     Text format     Abstract available

  6. SODO M, Spirito L, La Rocca R, Bracale U, et al
    Partial cystectomy in young male for a urachal tumor masquerading a bladder leiomyoma.
    Arch Ital Urol Androl. 2019;91:51-52.
    PubMed     Text format     Abstract available


    Asian J Transfus Sci

  7. JOSHI SR, Sheladiya A, Agrawal VN
    High thermal amplitude auto-anti-"N" complicating pretransfusion compatibility tests on a patient with malaria and bladder cancer.
    Asian J Transfus Sci. 2019;13:30-33.
    PubMed     Text format     Abstract available


    Biosci Biotechnol Biochem

  8. LEE JW, Lee S, Ho JN, Youn JI, et al
    Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells.
    Biosci Biotechnol Biochem. 2019 Jul 31:1-7. doi: 10.1080/09168451.2019.1648207.
    PubMed     Text format     Abstract available


    BMJ Open Gastroenterol

  9. HABERSTROH W, Shafa S
    Pseudoachalasia secondary to metastatic bladder cancer.
    BMJ Open Gastroenterol. 2019;6:e000284.
    PubMed     Text format     Abstract available


    Cancer

  10. TAKAHASHI T
    Overall survival is the primary endpoint in a trial of neoadjuvant chemotherapy for bladder cancer?
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32415.
    PubMed     Text format    


    Cancer Med

  11. BAE WK, Lee HJ, Park SH, Kim JH, et al
    Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analys
    Cancer Med. 2019 Jul 29. doi: 10.1002/cam4.2446.
    PubMed     Text format     Abstract available


    Cancer Sci

  12. HIROTSU Y, Yokoyama H, Amemiya K, Hagimoto T, et al
    Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer.
    Cancer Sci. 2019 Aug 1. doi: 10.1111/cas.14155.
    PubMed     Text format     Abstract available


    Cell Prolif

  13. LIU P, Li X, Guo X, Chen J, et al
    Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.
    Cell Prolif. 2019;52:e12614.
    PubMed     Text format     Abstract available


    Cell Signal

  14. LI X, He S, Tian Y, Weiss RM, et al
    Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth.
    Cell Signal. 2019 Jul 30:109381. doi: 10.1016/j.cellsig.2019.109381.
    PubMed     Text format     Abstract available


    Clin Sci (Lond)

  15. CHENG S, Wang G, Wang Y, Cai L, et al
    Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARgamma-mediated pathway in bladder cancer.
    Clin Sci (Lond). 2019 Jul 29. pii: CS20190587. doi: 10.1042/CS20190587.
    PubMed     Text format     Abstract available


    Dis Markers

  16. TIAN DW, Wu ZL, Jiang LM, Gao J, et al
    KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo.
    Dis Markers. 2019;2019:4824902.
    PubMed     Text format     Abstract available


    Eur Urol

  17. VOSKUILEN CS, van der Heijden MS, van Rhijn BWG
    Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Jul 24. pii: S0302-2838(19)30543.
    PubMed     Text format    

  18. ELANDER NO, Hussain SA
    Mutation Analysis of the FGFR3-encoding gene Does Not Predict Response to Checkpoint Inhibitor Treatment in Metastatic Bladder Cancer.
    Eur Urol. 2019 Jul 26. pii: S0302-2838(19)30593.
    PubMed     Text format    


    FASEB J

  19. YAN H, Ren S, Lin Q, Yu Y, et al
    Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
    FASEB J. 2019 Aug 2:fj201900499RR. doi: 10.1096/fj.201900499.
    PubMed     Text format     Abstract available


    Front Oncol

  20. ZHANG W, Mao S, Shi D, Zhang J, et al
    MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1.
    Front Oncol. 2019;9:619.
    PubMed     Text format     Abstract available

  21. LI Y, Zhang H, Guo Y, Cai H, et al
    A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I-III Bladder Cancer Patients After Surgical Resection.
    Front Oncol. 2019;9:629.
    PubMed     Text format     Abstract available


    Indian J Pathol Microbiol

  22. AGARWAL H, Babu S, Rana C, Kumar M, et al
    Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma.
    Indian J Pathol Microbiol. 2019;62:244-250.
    PubMed     Text format     Abstract available


    Int Braz J Urol

  23. LI J, Yang F, He Q, Wang M, et al
    Laparoscopic radical cystectomy with intracorporeal ileal conduit: one center experience and clinical outcomes.
    Int Braz J Urol. 2019;45:560-571.
    PubMed     Text format     Abstract available


    Int J Biol Sci

  24. LI A, Yao L, Fang Y, Yang K, et al
    Specifically blocking the fatty acid synthesis to inhibit the malignant phenotype of bladder cancer.
    Int J Biol Sci. 2019;15:1610-1617.
    PubMed     Text format     Abstract available

  25. QI F, Tan B, Ma F, Zhu B, et al
    A Synthetic Light-switchable System based on CRISPR Cas13a Regulates the Expression of LncRNA MALAT1 and Affects the Malignant Phenotype of Bladder Cancer Cells.
    Int J Biol Sci. 2019;15:1630-1636.
    PubMed     Text format     Abstract available


    Int J Urol

  26. YOSHIDA T, Kates M, Fujita K, Bivalacqua TJ, et al
    Predictive biomarkers for drug response in bladder cancer.
    Int J Urol. 2019 Aug 1. doi: 10.1111/iju.14082.
    PubMed     Text format     Abstract available

  27. FUJIMURA T
    Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
    Int J Urol. 2019 Jul 30. doi: 10.1111/iju.14076.
    PubMed     Text format     Abstract available

  28. TEISHIMA J, Matsubara A
    Editorial Comment to Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
    Int J Urol. 2019 Jul 30. doi: 10.1111/iju.14086.
    PubMed     Text format    

  29. KOJIMA T
    Editorial Comment from Dr Kojima to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, inductio
    Int J Urol. 2019 Jul 28. doi: 10.1111/iju.14074.
    PubMed     Text format    


    Intern Med

  30. OKANO H, Asakawa H, Nose K, Tsuruga S, et al
    Hepatic Injury without Granulomatous Formation Associated with Intravesical Bacillus Calmette-Guerin Therapy.
    Intern Med. 2019;58:1429-1432.
    PubMed     Text format     Abstract available


    J Am Osteopath Assoc

  31. MARTINGANO D, Ramirez LC, Bjurlin MA
    Osteopathic Evaluation of Urinary Retention Caused by Atypical Presentation of Invasive Cervical Cancer Mimicking Primary Urothelial Tumor.
    J Am Osteopath Assoc. 2018;118:685-688.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  32. KITAGAWA K, Shigemura K, Sung SY, Chen KC, et al
    Possible correlation of sonic hedgehog signaling with epithelial-mesenchymal transition in muscle-invasive bladder cancer progression.
    J Cancer Res Clin Oncol. 2019 Jul 31. pii: 10.1007/s00432-019-02987.
    PubMed     Text format     Abstract available


    J Carcinog

  33. SAMISHINA EA, Blinova EV, Roshchin DA, Suslova IR, et al
    Programmed death-ligand 1 signaling pathway involves in bladder cancer growth and progression.
    J Carcinog. 2019;18:3.
    PubMed     Text format     Abstract available


    J Clin Pathol

  34. MAGERS MJ, Kaimakliotis HZ, Barboza MP, Bandali E, et al
    Clinicopathological characteristics of ypT0N0 urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.
    J Clin Pathol. 2019;72:550-553.
    PubMed     Text format     Abstract available


    J Minim Invasive Gynecol

  35. SCHWARTZ E, Faller E, Akladios CY, Greget M, et al
    Total Laparoscopic Hysterectomy for Endometriosis and an Arteriovenous Malformation.
    J Minim Invasive Gynecol. 2019;26:363-364.
    PubMed     Text format     Abstract available


    J Urol

  36. CHANG SS
    Re: Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis.
    J Urol. 2019 Jul 31:10109701JU00005794608369953.
    PubMed     Text format    

  37. BJURLIN MA, Nielsen ME
    Editorial Comment.
    J Urol. 2019;202:246.
    PubMed     Text format    

  38. CHANG SS
    Re: Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model.
    J Urol. 2019 Jul 31:101097JU0000000000000479. doi: 10.1097/JU.0000000000000479.
    PubMed     Text format    

  39. CHANG SS
    Re: Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.
    J Urol. 2019 Jul 31:10109701JU00005794560657170.
    PubMed     Text format    


    Medicine (Baltimore)

  40. CALO B, Sanguedolce F, Fortunato F, Stallone G, et al
    The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer.
    Medicine (Baltimore). 2019;98:e16223.
    PubMed     Text format     Abstract available


    Mol Cancer

  41. FENG J, Chen K, Dong X, Xu X, et al
    Genome-wide identification of cancer-specific alternative splicing in circRNA.
    Mol Cancer. 2019;18:35.
    PubMed     Text format     Abstract available


    Nat Cell Biol

  42. CHEN X, Li A, Sun BF, Yang Y, et al
    5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs.
    Nat Cell Biol. 2019;21:978-990.
    PubMed     Text format     Abstract available


    Oncol Rep

  43. WANG F, Li Y, Shan F, Zhang Q, et al
    Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG.
    Oncol Rep. 2019 Jul 23. doi: 10.3892/or.2019.7246.
    PubMed     Text format     Abstract available

  44. TOLLE A, Buckendahl L, Jung K
    Plasma miR15b5p and miR5905p for distinguishing patients with bladder cancer from healthy individuals.
    Oncol Rep. 2019 Jul 24. doi: 10.3892/or.2019.7247.
    PubMed     Text format     Abstract available


    PLoS One

  45. JIANG WD, Yuan PC
    Molecular network-based identification of competing endogenous RNAs in bladder cancer.
    PLoS One. 2019;14:e0220118.
    PubMed     Text format     Abstract available

  46. KAWAHARA T, Kojima T, Kandori S, Kurobe M, et al
    TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.
    PLoS One. 2019;14:e0220173.
    PubMed     Text format     Abstract available


    Prog Urol

  47. BABOUDJIAN M, Lechevallier E, Michel F, Ben Othman K, et al
    [Does diagnostic ureterorenoscopy increase the risk of bladder recurrence after total nephroureterectomy? A review of the literature].
    Prog Urol. 2019;29:138-146.
    PubMed     Text format     Abstract available


    Urol Oncol

  48. GENITSCH V, Kollar A, Vandekerkhove G, Blarer J, et al
    Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Urol Oncol. 2019 Jul 26. pii: S1078-1439(19)30250.
    PubMed     Text format     Abstract available


    Urologe A

  49. HUPE MC, Gakis G, Seiler R
    [Molecular tumor board-urothelial cancer].
    Urologe A. 2019;58:760-767.
    PubMed     Text format     Abstract available


    World J Urol

  50. BLACK PC
    Hope, hype and biology: the current biomarker landscape in bladder cancer.
    World J Urol. 2019 Jul 27. pii: 10.1007/s00345-019-02885.
    PubMed     Text format    

  51. REIS LO
    Non-muscle invasive bladder cancer (NMIBC): boiling arena and promissory future.
    World J Urol. 2019 Aug 1. pii: 10.1007/s00345-019-02894.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: